ALS — real improvements and ongoing support

Clinical Case Observation: Amyotrophic Lateral Sclerosis (ALS)

Patient: Rebecca | Italy

Patient Background

Rebecca, a woman from Italy, was diagnosed with amyotrophic lateral sclerosis (ALS) in July 2023. The initial symptoms presented in one lower limb and gradually progressed to involve the upper extremities and speech function, reflecting a typical pattern of disease progression.

At the time of presentation at BioCells Medical, the condition was associated with increasing motor limitations, reduced muscle control, and emerging difficulties with speech clarity.

Clinical Approach at BioCells Medical

Rebecca began an individualised regenerative medicine programme at BioCells Medical, developed by the medical team based on her neurological status, symptom distribution, and overall clinical assessment.

The first stage of treatment was completed approximately one month prior to the current evaluation and included cell-based therapeutic interventions aimed at supporting neuronal function and modulating inflammatory processes. All procedures were performed under medical supervision within a structured clinical framework.

Post-Treatment Observations

Following the initial treatment stage, functional changes were reported by the patient’s spouse, Marika, and monitored during follow-up communication with the medical team. Observed changes included:

• improved mobility of the lower lip, with clearer and more intelligible speech,

• relaxation of the hands, which had previously remained clenched, with restored voluntary movement of the index fingers,

• increased overall strength and functional independence, allowing the patient to transfer independently from bed to wheelchair and from wheelchair to car,

• improved mobility in the leg initially affected by the condition, with restored movement in the gluteal and thigh muscle groups.

These changes contributed to greater physical confidence and improved daily functioning.

Follow-Up and Ongoing Monitoring

Rebecca remains under continued medical observation following the first treatment stage. Her family is currently preparing for the next treatment cycle, with the goal of further supporting neurological function, motor strength, and overall physical stability.

Clinical monitoring and treatment planning continue to be guided by her individual response and functional dynamics.

Clinical Context

This clinical case highlights the potential functional changes that may be observed following a personalised regenerative medicine approach in a patient with ALS. At BioCells Medical, each treatment programme is tailored to the individual patient’s condition, disease progression, and functional priorities, with close medical oversight throughout the process.

Medical Consultation

Patients and families affected by ALS who are seeking professional medical guidance may request a free medical consultation with the BioCells Medical team.

Each case is evaluated individually to determine whether a personalised regenerative medicine strategy may be appropriate.